SUTRO BIOPHARMA, INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Sutro Biopharma, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q3 2024.
  • Sutro Biopharma, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $19M, a 20.7% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $19M -$4.97M -20.7% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $20.3M -$4.81M -19.1% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $21.6M -$4.21M -16.3% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $22.8M -$3.63M -13.7% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 $24M -$3.08M -11.4% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $25.1M -$2.58M -9.3% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $25.8M -$2.57M -9.06% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $26.4M -$2.6M -8.95% Dec 31, 2022 10-K 2024-03-25
Q3 2022 $27.1M -$3.06M -10.1% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $27.7M Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $28.4M Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $29M -$659K -2.22% Dec 31, 2021 10-K 2023-03-30
Q3 2021 $30.1M Sep 30, 2021 10-Q 2021-11-10
Q4 2020 $29.7M Jan 1, 2021 10-K 2022-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.